Search Results - "DE RYCKE, Yann"

Estimation of conditional and marginal odds ratios using the prognostic score by Hajage, David, De Rycke, Yann, Chauvet, Guillaume, Tubach, Florence

“…Introduced by Hansen in 2008, the prognostic score (PGS) has been presented as ‘the prognostic analogue of the propensity score’ (PPS). PPS‐based methods are…”
Get full text

Health-related quality of life of COVID-19 two and 12 months after intensive care unit admission by Demoule, Alexandre, Morawiec, Elise, Decavele, Maxens, Ohayon, Raphaelle, Malrin, Roxane, Galarza-Jimenez, Maria Alejandra, Laveneziana, Pierantonio, Morelot-Panzini, Capucine, Similowski, Thomas, De Rycke, Yann, Gonzalez-Bermejo, Jesus

“…Purpose To describe health-related quality of life (HRQoL) and dyspnea of COVID-19, 2 and 12 months after an intensive care unit (ICU) stay . Methods Patients…”
Get full text

Bacterial Floras and Biofilms of Malignant Wounds Associated with Breast Cancers by Fromantin, Isabelle, Seyer, Damien, Watson, Sarah, Rollot, Florence, Elard, Jacqueline, Escande, Marie Christine, De Rycke, Yann, Kriegel, Irène, Larreta Garde, Véronique

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review by Belin, Lisa, Tan, Aidan, De Rycke, Yann, Dechartres, Agnès

“…Background Progression-free survival (PFS) is a surrogate endpoint widely used for overall survival (OS) in oncology. Validation of PFS as a surrogate must be…”
Get full text

Dynamic evaluation of MRI-targeted, systematic and combined biopsy for prostate cancer diagnosis through 10 years of practice in a single institution by Lenfant, Louis, Renard-Penna, Raphaele, de Rycke, Yann, Rouprêt, Morgan, Beaugerie, Aurelien, Comperat, Eva, Chartier-Kastler, Emmanuel, Mozer, Pierre C.

“…Purpose To perform a dynamic evaluation of the prostate cancer (PCa) detection rate according to the biopsy strategy over 10 years of practice in a single…”
Get full text

Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues by Brieau, Bertrand, Dahan, Laetitia, De Rycke, Yann, Boussaha, Tarek, Vasseur, Philippe, Tougeron, David, Lecomte, Thierry, Coriat, Romain, Bachet, Jean‐Baptiste, Claudez, Pierre, Zaanan, Aziz, Soibinet, Pauline, Desrame, Jérome, Thirot‐Bidault, Anne, Trouilloud, Isabelle, Mary, Florence, Marthey, Lysiane, Taieb, Julien, Cacheux, Wulfran, Lièvre, Astrid

“…BACKGROUND Few data are available on second‐line chemotherapy (CT2) for advanced biliary tract cancer (ABTC). The aim of this multicenter study was to describe…”
Get full text

Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data by Massol, Julien, Simon-Tillaux, Noémie, Tohme, Joanna, Hariri, Geoffroy, Dureau, Pauline, Duceau, Baptiste, Belin, Lisa, Hajage, David, De Rycke, Yann, Charfeddine, Ahmed, Lebreton, Guillaume, Combes, Alain, Bouglé, Adrien

“…Retrospective cohorts have suggested that levosimendan may facilitate the weaning of veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We therefore…”
Get full text

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review by Gault, Nathalie, Castañeda-Sanabria, Johann, De Rycke, Yann, Guillo, Sylvie, Foulon, Stéphanie, Tubach, Florence

“…Observational studies are widely used in pharmacoepidemiology. Several designs can be used, in particular self-controlled designs (case-crossover and…”
Get full text

Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France by de Rycke, Yann, Tubach, Florence, Lafourcade, Alexandre, Guillo, Sylvie, Dalichampt, Marie, Dahlab, André, Bresse, Xavier, Uhart, Mathieu, Bergeron, Christine, Borne, Hélène, Cancalon, Charlotte, Lajoinie, Audrey, Bénard, Stève

“…Until 2018, cervical cancer screening in France was an unorganized individual screening, with the exception of some pilot programs in some territories. We…”
Get full text

A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage Design by Belin, Lisa, Broët, Philippe, De Rycke, Yann

“…For phase II oncology trials, Simon's two-stage design is the most commonly used strategy. However, when clinically unevaluable patients occur, the total…”
Get full text

The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma by Reyal, Fabien, Rouzier, Roman, Depont-Hazelzet, Berenice, Bollet, Marc A, Pierga, Jean-Yves, Alran, Severine, Salmon, Remy J, Fourchotte, Virginie, Vincent-Salomon, Anne, Sastre-Garau, Xavier, Antoine, Martine, Uzan, Serge, Sigal-Zafrani, Brigitte, De Rycke, Yann

“…Several authors have underscored a strong relation between the molecular subtypes and the axillary status of breast cancer patients. The aim of our work was to…”
Get full text

On the use of propensity scores in case of rare exposure by Hajage, David, Tubach, Florence, Steg, Philippe Gabriel, Bhatt, Deepak L, De Rycke, Yann

“…Observational post-marketing assessment studies often involve evaluating the effect of a rare treatment on a time-to-event outcome, through the estimation of a…”
Get full text

Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database by Seror, Raphaele, Lafourcade, Alexandre, De Rycke, Yann, Pinto, Sandrine, Castaneda, Johann, Fautrel, Bruno, Mariette, Xavier, Tubach, Florence

“…ObjectiveTo compare the risk of malignancy between patients with rheumatoid arthritis (RA) initiating their first biological disease-modifying antirheumatic…”
Get full text

Matching methods to create paired survival data based on an exposure occurring over time: a simulation study with application to breast cancer by Savignoni, Alexia, Giard, Caroline, Tubert-Bitter, Pascale, Rycke, Yann De

“…Paired survival data are often used in clinical research to assess the prognostic effect of an exposure. Matching generates correlated censored data expecting…”
Get full text

Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse by BIDARD, Francois-Clément, VINCENT-SALOMON, Anne, GOMME, Stéphanie, NOS, Claude, DE RYCKE, Yann, THIERY, Jean Paul, SIGAL-ZAFRANI, Brigitte, MIGNOT, Laurent, SASTRE-GARAU, Xavier, PIERGA, Jean-Yves

“…Purpose: Clinical significance of disseminated tumor cells (DTC) in bone marrow of early breast cancer patients has been reported, but improvements in…”
Get full text

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up by Belin, Lisa, De Rycke, Yann, Broët, Philippe

“…Abstract In phase II oncology trials, the use of new cytostatic drugs raises some questions regarding the endpoint. Time-to-event endpoints such as…”
Get full text

Effect of an event occurring over time and confounded by health status: estimation and interpretation. A study based on survival data simulations with application on breast cancer by Savignoni, Alexia, Hajage, David, Tubert-Bitter, Pascale, Rycke, Yann De

“…Estimating the prognostic effect of a time‐dependent covariate could be tricky using a classical Cox model, despite adjustment on other known prognostic…”
Get full text

Risk of Second Malignancies After Adjuvant Radiotherapy for Breast Cancer: A Large-Scale, Single-Institution Review by Kirova, Youlia M., M.D, Gambotti, Laetitia, M.D, De Rycke, Yann, Ph.D, Vilcoq, Jacques R., M.D, Asselain, Bernard, M.D, Fourquet, Alain, M.D

“…Purpose: The aim of this study was to estimate the risk of second malignancies (SM) after radiation therapy (RT) for breast cancer (BC) in a large,…”
Get full text

Targeting population entering phase III trials: A new stratified adaptive phase II design by Tournoux-Facon, Caroline, Rycke, Yann De, Tubert-Bitter, Pascale

“…The primary goal of phase II studies is to assess the efficacy of the new treatment in order to decide whether it has sufficient activity to warrant further…”
Get full text

A prognostic DNA signature for T1T2 node-negative breast cancer patients by Gravier, Eléonore, Pierron, Gaëlle, Vincent-Salomon, Anne, Gruel, Nadège, Raynal, Virginie, Savignoni, Alexia, De Rycke, Yann, Pierga, Jean-Yves, Lucchesi, Carlo, Reyal, Fabien, Fourquet, Alain, Roman-Roman, Sergio, Radvanyi, François, Sastre-Garau, Xavier, Asselain, Bernard, Delattre, Olivier

“…Predicting evolution of small node‐negative breast carcinoma is a real challenge in clinical practice. The aim of this study was to search whether qualitative…”
Get full text